Compass Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Compass Capital Management's AMGN Position: Q3 2026 in Review
Compass Capital Management increased its Amgen (AMGN) stake by 27% in Q3 2026, buying an estimated $199K and bringing the position to 2,345 shares worth $988K. The position accounts for 0.06% of the portfolio, ranked #65.
Compass Capital Management first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Compass Capital Management held 2,345 shares of Amgen worth $988K as of Q3 2026.
- Compass Capital Management bought 500 Amgen shares in Q3 2026, an estimated $199K.
- Amgen made up 0.06% of Compass Capital Management's portfolio in Q3 2026, its #65 holding.
- Compass Capital Management first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Compass Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.